Roche secures CE mark for groundbreaking Vaginitis test that promises accurate diagnosis
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Roche says the move marks a step forward in its digital transformation strategy
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Subscribe To Our Newsletter & Stay Updated